DC

Decheng Capital Portfolio holdings

AUM $396M
This Quarter Return
-22.23%
1 Year Return
-5.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$326M
AUM Growth
+$326M
Cap. Flow
-$302M
Cap. Flow %
-92.57%
Top 10 Hldgs %
86.05%
Holding
28
New
6
Increased
3
Reduced
1
Closed
4

Top Buys

1
NUVB icon
Nuvation Bio
NUVB
$20.3M
2
NAMS icon
NewAmsterdam Pharma
NAMS
$7.68M
3
MRUS icon
Merus
MRUS
$4.57M
4
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$3.97M
5
VERA icon
Vera Therapeutics
VERA
$2.52M

Top Sells

1
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$330M
2
TXG icon
10x Genomics
TXG
$7.35M
3
ILMN icon
Illumina
ILMN
$2.12M
4
HLTH
Cue Health Inc. Common Stock
HLTH
$1.7M
5
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$1.23M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CGON icon
1
CG Oncology
CGON
$2.04B
$172M 52.81% 5,458,810 – –
NUVB icon
2
Nuvation Bio
NUVB
$1.02B
$20.3M 6.22% +6,950,239 New +$20.3M
RCUS icon
3
Arcus Biosciences
RCUS
$1.13B
$13.2M 4.06% 869,790 – –
ZNTL icon
4
Zentalis Pharmaceuticals
ZNTL
$122M
$12.6M 3.85% 3,070,442 +970,859 +46% +$3.97M
KRYS icon
5
Krystal Biotech
KRYS
$4.27B
$12.1M 3.7% 65,772 – –
BYSI icon
6
BeyondSpring
BYSI
$69.4M
$11.9M 3.65% 4,958,143 – –
ILMN icon
7
Illumina
ILMN
$15.8B
$11.4M 3.48% 108,767 -20,300 -16% -$2.12M
MRUS icon
8
Merus
MRUS
$4.98B
$10.6M 3.25% 179,098 +77,300 +76% +$4.57M
PHAT icon
9
Phathom Pharmaceuticals
PHAT
$864M
$8.76M 2.68% 850,000 – –
NAMS icon
10
NewAmsterdam Pharma
NAMS
$2.71B
$7.68M 2.35% +400,000 New +$7.68M
MLTX icon
11
MoonLake Immunotherapeutics
MLTX
$3.54B
$7.33M 2.24% 166,600 – –
FDMT icon
12
4D Molecular Therapeutics
FDMT
$288M
$7.3M 2.24% 347,835 – –
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$2.92B
$7.07M 2.17% 157,958 – –
CYTK icon
14
Cytokinetics
CYTK
$4.23B
$5.1M 1.56% 94,043 – –
LEGN icon
15
Legend Biotech
LEGN
$6.41B
$4.37M 1.34% 98,558 +12,195 +14% +$540K
AURA icon
16
Aura Biosciences
AURA
$389M
$3.9M 1.19% 515,555 – –
EQ icon
17
Equillium
EQ
$62.2M
$3.08M 0.94% 4,447,308 – –
WGS icon
18
GeneDx Holdings
WGS
$3.72B
$2.71M 0.83% 103,604 – –
VERA icon
19
Vera Therapeutics
VERA
$1.38B
$2.52M 0.77% +69,767 New +$2.52M
PYXS icon
20
Pyxis Oncology
PYXS
$79.4M
$1.08M 0.33% 326,810 – –
ATRC icon
21
AtriCure
ATRC
$1.84B
$610K 0.19% 26,797 – –
GRAL
22
GRAIL, Inc. Common Stock
GRAL
$1.18B
$279K 0.09% +18,127 New +$279K
NUVB.WS icon
23
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$103K 0.03% +646,057 New +$103K
ACLX icon
24
Arcellx
ACLX
$3.85B
$65K 0.02% +1,177 New +$65K
TXG icon
25
10x Genomics
TXG
$1.74B
– – -195,835 Closed -$7.35M
1
2